RxDoctor Payments Data

Leslie Taylor

Family · Clarksville, TNNPI 1265901649

Payments from drug & device makers

$1,797in general payments, 2019–2025

Across 106 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$268
  • Novo Nordisk$248
  • Novartis$221
  • Amgen$203
  • Lilly USA, LLC$147
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$131
  • plus $580 from 12 others

What the payments were for

  • Food & beverage$1,797100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,797 in reported general payments places this provider in the 75th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide74$75,800
FarxigaDapagliflozin Propanediol71$55,671
OzempicSemaglutide55$51,916
TrulicityDulaglutide18$28,510
XareltoRivaroxaban19$19,444
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$16,900
RayaldeeCalcifediol11$12,855
LinzessLinaclotide14$9,385
Repatha SureclickEvolocumab18$9,328
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$6,436
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$3,099
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate19$1,375
Diclofenac Sodium12$1,249
Atorvastatin Calcium200$1,193
Omeprazole100$1,161

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$147$104,31092 claims
AstraZenecaFarxiga$85$55,67171 claims
Novo NordiskOzempic$248$51,91655 claims
GSKTrelegy Ellipta$29$16,90023 claims
AbbVieLinzess$268$9,38514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,706 family providers in Tennessee.

Other family in Clarksville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →